Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
The "A-B-C" Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab.
Claudia Campani, Clelia Galvanin, Ju Hyun Shim, Mohamed Bouattour, Yann Touchefeu, Victoria Delhoume, Olivier Rosmorduc, Alina Pascale, Jihyun An, Han Chu Lee, Helene Regnault, Dominique Thabut, Valérie Paradis, Julien Calderaro, Marianne Ziol
Published: 202510.1016/j.cgh.2025.11.018
Abstract
BACKGROUND & AIMS: We aimed to identify subgroups of patients with unresectable hepatocellular carcinoma (HCC) using a non a priori, data-driven machine learning approach to uncover subgroups with distinct profiles across a range of clinical and tumo…
Preview only. Read the full abstract at the source